Relief as Amarin agrees $70 million financing
This article was originally published in Scrip
Executive Summary
The Irish biotechnology company Amarin, which is listed on Nasdaq in the US, has agreed a fundraising of $70 million through a private placement, ending months of concern over its financial health.